/ Print /

Health/Disease Strategy

Stem cell therapy shows promise for COPD, but questions remainAutologous stem cell therapy may offer hope for patients with COPD. But some say caution is necessary.
Study defines ‘low-value care,’ evaluates toll on healthcare industryA new study led by UCLA researchers has eye-opening findings about low-cost, high-volume unnecessary healthcare. These low-value services may surprise you.
Federal program aimed at reducing readmissions raises concernsA new study has shocking findings about death rates in heart failure patients enrolled in the Hospital Readmissions Reduction Program.
Patient experience with immunotherapy: 4 things health execs need to knowCAR T-cell therapies and other immunotherapy give this oncologist’s cancer patients hope for a better quality of life.
Why MS relapse rates are underreported: What health execs should knowTwo patient survey studies sponsored by Mallinckrodt reveal findings about patient-reported multiple sclerosis rates.
Two asthma treatment recommendations for health organizationsAllergist Bradley Chipps, MD, shares research on how to fine-tune asthma management strategies.
Landmark study identifies asthma in infantsA Canadian study reveals how clinicians may be able to identify whether asthma will develop in patients as young as age one.
Four oncology treatment advances to watch
Four oncology treatment advances to watchExperts say a cancer care revolution is here. Here’s a closer look at some advancements in cancer treatments to watch.
Genetic testing: 3 things managed healthcare executives should knowA new survey on genetic testing has surprisingly results on consumer acceptance and impact for healthcare executives.
Here’s a more effective way to test for HPVA Kaiser Permanente study found that a new way to test for HPV has the potential to increase efficiency and decrease waste.